title: Hyperbaric oxygen therapy for hemorrhagic cystitis.
authors.affiliation: Pediatric Hematology-Oncology Division, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey.
authors.forename: Müge
authors.initials: M
authors.lastname: Gökçe
authors.forename: Arzu
authors.initials: A
authors.lastname: Akçay
authors.forename: Deniz
authors.initials: D
authors.lastname: Tuğcu
authors.forename: Merve
authors.initials: M
authors.lastname: Erdemir
authors.forename: Bengüsu
authors.initials: B
authors.lastname: Mirasoğlu
mesh_terms: D000293:Adolescent; D001739:BK Virus / Q000276:immunology / Q000472:pathogenicity*; D003556:Cystitis / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006417:Hematuria / Q000821:virology; D006470:Hemorrhage / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D006801:Humans; D006931:Hyperbaric Oxygenation; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000276:immunology / Q000821:virology*; D027601:Polyomavirus Infections / Q000175:diagnosis / Q000276:immunology / Q000821:virology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000276:immunology / Q000821:virology*
chemical_list: D007166:Immunosuppressive Agents